应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02192 医脉通
交易中 09-20 10:51:51
7.820
+0.170
+2.22%
最高
7.880
最低
7.760
成交量
6.10万
今开
7.800
昨收
7.650
日振幅
1.57%
总市值
57.31亿
流通市值
57.31亿
总股本
7.33亿
成交额
47.65万
换手率
0.01%
流通股本
7.33亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
医脉通(02192)下跌7.32%,报7.09元/股
金融界 · 09-16
医脉通(02192)下跌7.32%,报7.09元/股
医脉通(02192)股价下跌5.229%,现价港币$7.25
阿斯达克财经 · 09-16
医脉通(02192)股价下跌5.229%,现价港币$7.25
南向资金8月29日净买入医脉通22.55万股 连续5日增持
市场透视 · 08-30
南向资金8月29日净买入医脉通22.55万股 连续5日增持
异动解读 | 医脉通中期业绩出色 股价大涨14.6%
异动解读 · 08-28
异动解读 | 医脉通中期业绩出色 股价大涨14.6%
医脉通(02192)用户活跃度持续提升,精准营销收入高增
国金证券 · 08-28
医脉通(02192)用户活跃度持续提升,精准营销收入高增
营收、利润双双大增!医脉通股价一度涨超15%
财华社 · 08-28
营收、利润双双大增!医脉通股价一度涨超15%
【港股通】医脉通(02192)涨逾10% 中期溢利、收入均同比增长超40%
金吾财讯 · 08-28
【港股通】医脉通(02192)涨逾10% 中期溢利、收入均同比增长超40%
医脉通(02192)股价显著上升11.995%,现价港币$8.59
阿斯达克财经 · 08-28
医脉通(02192)股价显著上升11.995%,现价港币$8.59
医脉通绩后持续上涨超7% 经调整净溢利同比增加30.30%
新浪港股 · 08-28
医脉通绩后持续上涨超7% 经调整净溢利同比增加30.30%
异动解读 | 医脉通半年报业绩亮眼 股价大涨7.43%
异动解读 · 08-28
异动解读 | 医脉通半年报业绩亮眼 股价大涨7.43%
港股异动 | 医脉通(02192)绩后涨超6% 经调整净溢利同比增超三成 净利润率继续保持较高水平
智通财经 · 08-28
港股异动 | 医脉通(02192)绩后涨超6% 经调整净溢利同比增超三成 净利润率继续保持较高水平
港股异动 | 医脉通(02192)涨超6% 上半年纯利同比增长48.6% 精准营销业务稳步提升
智通财经 · 08-28
港股异动 | 医脉通(02192)涨超6% 上半年纯利同比增长48.6% 精准营销业务稳步提升
医脉通(02192)上涨5.61%,报8.1元/股
金融界 · 08-28
医脉通(02192)上涨5.61%,报8.1元/股
南向资金8月27日净买入医脉通0.65万股 连续3日增持
市场透视 · 08-28
南向资金8月27日净买入医脉通0.65万股 连续3日增持
【港股通】医脉通(02192)中期溢利增长48.62% 派中期股息0.1205元人民币
金吾财讯 · 08-27
【港股通】医脉通(02192)中期溢利增长48.62% 派中期股息0.1205元人民币
医脉通(02192.HK)上半年净利润超1.5亿元 同比增长50.2%
格隆汇 · 08-27
医脉通(02192.HK)上半年净利润超1.5亿元 同比增长50.2%
医脉通(02192)将于11月18日派发中期股息每股0.1205元
智通财经网 · 08-27
医脉通(02192)将于11月18日派发中期股息每股0.1205元
医脉通(02192)发布中期业绩,经调整净溢利1.56亿元 同比增加30.3%
智通财经网 · 08-27
医脉通(02192)发布中期业绩,经调整净溢利1.56亿元 同比增加30.3%
《业绩》医脉通(02192.HK)半年纯利1.47亿元人民币升48.6% 中期息12.05分人民币
阿斯达克财经 · 08-27
《业绩》医脉通(02192.HK)半年纯利1.47亿元人民币升48.6% 中期息12.05分人民币
医脉通(02192.HK)拟8月27日举行董事会会议批准中期业绩
格隆汇 · 08-08
医脉通(02192.HK)拟8月27日举行董事会会议批准中期业绩
加载更多
公司概况
公司名称:
医脉通
所属市场:
SEHK
上市日期:
--
主营业务:
医脉通科技有限公司是一家主要运营在线专业医师平台的中国投资控股公司。该公司运营三个业务部门。精准营销及企业解决方案部门包括精准营销解决方案及企业解决方案。其中精准营销解决方案包括数字推送、营销咨询以及内容创建服务。企业解决方案的收益主要是软件即服务(SaaS)。医学知识解决方案部门主要提供专业医学信息和医疗软件服务。智能患者管理解决方案部门主要提供线上患者咨询及处方服务和患者管理服务。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02192","market":"HK","secType":"STK","nameCN":"医脉通","latestPrice":7.82,"timestamp":1726800612052,"preClose":7.65,"halted":0,"volume":61000,"delay":0,"floatShares":732851000,"shares":732851000,"eps":0.37032202,"marketStatus":"交易中","marketStatusCode":2,"change":0.17,"latestTime":"09-20 10:51:51","open":7.8,"high":7.88,"low":7.76,"amount":476470,"amplitude":0.015686,"askPrice":7.85,"askSize":12000,"bidPrice":7.81,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":0.4354001840194459,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1726804800000},"adr":0,"listingDate":1626278400000,"adjPreClose":7.65,"dividendRate":0.034571,"openAndCloseTimeList":[[1726795800000,1726804800000],[1726808400000,1726819200000]],"volumeRatio":0.28595,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02192","defaultTab":"news","newsList":[{"id":"2467895031","title":"医脉通(02192)下跌7.32%,报7.09元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2467895031","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467895031?lang=zh_cn&edition=full","pubTime":"2024-09-16 15:06","pubTimestamp":1726470379,"startTime":"0","endTime":"0","summary":"9月16日,医脉通(02192)盘中下跌7.32%,截至15:06,报7.09元/股,成交765.77万元。医脉通科技有限公司主要业务是开发医药学工具软件,包括《全医药学大词典》、《临床用药参考》、《医学文献王》等,并创建了拥有超过300万注册医生的《医脉通》平台。此外,公司还为药企提供精准、高效的数字营销服务,已发展成为专业的医学信息服务及精准数字营销服务提供商。截至2024年中报,医脉通营业总收入2.43亿元、净利润1.47亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/16150643306596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02192","BK1189","BK1587"],"gpt_icon":0},{"id":"2467867599","title":"医脉通(02192)股价下跌5.229%,现价港币$7.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2467867599","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467867599?lang=zh_cn&edition=full","pubTime":"2024-09-16 13:22","pubTimestamp":1726464120,"startTime":"0","endTime":"0","summary":"[下跌股]医脉通(02192) 股价在下午01:22比前收市价下跌5.229%,现股价为港币$7.25。至目前为止,今日最高价为$7.99,而最低价为$7.25。总成交量为60.9万股,总成交金额为港币$452.599万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2409161137/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1189","BK1587","02192"],"gpt_icon":0},{"id":"2463421202","title":"南向资金8月29日净买入医脉通22.55万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2463421202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463421202?lang=zh_cn&edition=full","pubTime":"2024-08-30 09:30","pubTimestamp":1724981412,"startTime":"0","endTime":"0","summary":"8月29日, 南向资金增持医脉通22.55万股,连续5日增持。截止当日收盘,港股通共持有医脉通2011.36万股,占流通股2.73%。医脉通近5个交易日上涨8.09%,港股通累计增持38.40万股;近20个交易日上涨9.71%,港股通累计增持62.81万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408300932359f67286e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408300932359f67286e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","BK1587","02192"],"gpt_icon":0},{"id":"1181940787","title":"异动解读 | 医脉通中期业绩出色 股价大涨14.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181940787","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181940787?lang=zh_cn&edition=full","pubTime":"2024-08-28 17:44","pubTimestamp":1724838269,"startTime":"0","endTime":"0","summary":"医脉通今日股价大涨14.6%,报收8.72港元,引发市场广泛关注。这主要得益于公司于8月27日公布的2024年中期业绩表现亮眼。财报显示,医脉通2024年上半年实现营收2.43亿元人民币,同比大增40.3%;净利润1.47亿元人民币,同比猛增48.6%;调整后净利润也同比增长30.3%至1.56亿元人民币。上佳的业绩表现远超市场预期,成为推动股价大涨的主要驱动力。上半年,该业务覆盖的客户数同比增加34家,覆盖的产品数量也同比增长32.8%,进一步彰显出公司在该领域的竞争优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"gpt_icon":0},{"id":"2462431671","title":"医脉通(02192)用户活跃度持续提升,精准营销收入高增","url":"https://stock-news.laohu8.com/highlight/detail?id=2462431671","media":"国金证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462431671?lang=zh_cn&edition=full","pubTime":"2024-08-28 17:14","pubTimestamp":1724836478,"startTime":"0","endTime":"0","summary":"经营分析医脉通平台用户数及活跃度持续提升,注册用户数近700万人,其中执业医师数超过400万人,覆盖全国执业医师的88%;平台月活量达到250万人,同比增长13.6%。较高的医师覆盖率和用户活跃度为公司开展精准营销及智能患者管理解决方案提供了坚实的基础。分业务而言,精准营销及企业解决方案收入为2.26亿元,同比增长42.7%。医学知识解决方案收入为842.2万元,同比增长4.5%,主要系用户数量增长所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082817311795cbe72a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082817311795cbe72a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02192","BK1587","BK1189"],"gpt_icon":0},{"id":"2462548207","title":"营收、利润双双大增!医脉通股价一度涨超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462548207","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462548207?lang=zh_cn&edition=full","pubTime":"2024-08-28 15:58","pubTimestamp":1724831913,"startTime":"0","endTime":"0","summary":"8月28日,国内最大的在线专业医生平台——医脉通(02192.HK)股价展现出强劲的走势,盘中最高涨幅达15.12%;截至发稿前,该股涨幅有所收窄,涨幅为5.87%,报8.12港元/股。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202408_1/24941d32-a703-4388-8e29-0f99b23f362d.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202408_1/24941d32-a703-4388-8e29-0f99b23f362d.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/66ced8a9bde0b36975c18dbb","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["02192"],"gpt_icon":0},{"id":"2462817011","title":"【港股通】医脉通(02192)涨逾10% 中期溢利、收入均同比增长超40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462817011","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462817011?lang=zh_cn&edition=full","pubTime":"2024-08-28 11:16","pubTimestamp":1724814961,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医脉通 早盘震荡走高,截至发稿,报8.44港元,涨10.04%,成交额1616.26万港元。消息面上,公司发布截至2024年6月30日止六个月中期业绩,录得母公司拥有人应占溢利1.47亿元,同比增长48.62%,每股基本盈利20.18分。期内,集团收益2.43亿元,同比增长40.31%;毛利为1.47亿元,同比增长40.02%。国金证券表示,根据2024年中报,该行预计2024-2026年公司实现营业收入5.41/7.12/9.28亿元,同比增长31.4%/31.5%/30.4%;实现归母净利润2.67/2.84/3.04亿元,同比增长10.3%/6.2%/7.0%,对应19.3/18.2/17.0倍PE,维持“买入”评级。","market":"sg","thumbnail":"https://static.szfiu.com/news/20200915/NWNhYTJjYTdkNzllNGFmZDMzMTYwMDE1MDIxMjI0Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NWNhYTJjYTdkNzllNGFmZDMzMTYwMDE1MDIxMjI0Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1943184","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","BK1189","07226","YANG","HSCEI","02192","BK1587"],"gpt_icon":0},{"id":"2462701851","title":"医脉通(02192)股价显著上升11.995%,现价港币$8.59","url":"https://stock-news.laohu8.com/highlight/detail?id=2462701851","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462701851?lang=zh_cn&edition=full","pubTime":"2024-08-28 11:09","pubTimestamp":1724814540,"startTime":"0","endTime":"0","summary":"[上升股]医脉通(02192) 股价在上午11:09比前收市价显著上升11.995%,现股价为港币$8.59。至目前为止,今日最高价为$8.59,而最低价为$7.67。总成交量为230.7万股,总成交金额为港币$1.898千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2408281613/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02192","BK1587","BK1189"],"gpt_icon":0},{"id":"2462417248","title":"医脉通绩后持续上涨超7% 经调整净溢利同比增加30.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462417248","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462417248?lang=zh_cn&edition=full","pubTime":"2024-08-28 10:46","pubTimestamp":1724813163,"startTime":"0","endTime":"0","summary":"医脉通(02192)绩后持续走高,股价上涨7.43%,报8.24港元,成交额1128.777万港元。\n 医脉通发布截至2024年6月30日止6个月中期业绩,该集团取得收益人民币2.43亿元(单位下同),同比增加40.3%;母公司拥有人应占溢利1.47亿元,同比增加48.6%;非香港财务报告准则经调整净溢利1.56亿元,同比增加30.3%;每股基本盈利20.18分,拟派发中期股息每股12.05分。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-08-28/doc-incmehfn5195517.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-08-28/doc-incmehfn5195517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02192","BK1587","BK1189"],"gpt_icon":0},{"id":"1116073774","title":"异动解读 | 医脉通半年报业绩亮眼 股价大涨7.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116073774","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116073774?lang=zh_cn&edition=full","pubTime":"2024-08-28 10:32","pubTimestamp":1724812346,"startTime":"0","endTime":"0","summary":"港股医脉通股价今日盘中大涨7.43%,引发市场广泛关注。这主要得益于公司2024年中期业绩表现亮眼。医脉通2024年上半年收益达2.43亿元人民币,同比大涨40.3%;母公司净利润1.47亿元人民币,同比增长48.6%;非香港财务报告准则经调整净利润也同比增加30.3%至1.56亿元人民币。良好的业绩表现超出市场预期,推动了其股价上扬。上半年该业务覆盖的客户数量同比增加34家,覆盖产品数量同比增长32.8%。同时,近期南向资金持续增持该股,亦展现了机构资金对公司的青睐程度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02192"],"gpt_icon":0},{"id":"2462174909","title":"港股异动 | 医脉通(02192)绩后涨超6% 经调整净溢利同比增超三成 净利润率继续保持较高水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2462174909","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462174909?lang=zh_cn&edition=full","pubTime":"2024-08-28 10:31","pubTimestamp":1724812293,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,医脉通绩后涨超6%,截至发稿,涨6.52%,报8.13港元,成交额713.9万港元。消息面上,医脉通发布截至2024年6月30日止6个月中期业绩,该集团取得收益人民币2.43亿元,同比增加40.3%;母公司拥有人应占溢利1.47亿元,同比增加48.6%;非香港财务报告准则经调整净溢利1.56亿元,同比增加30.3%;每股基本盈利20.18分,拟派发中期股息每股12.05分。截至2024年6月30日止6个月的经调整净利润和经调整净利润率分别为1.56亿元和64.1%,继续在行业中保持领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1172834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02192"],"gpt_icon":0},{"id":"2462174837","title":"港股异动 | 医脉通(02192)涨超6% 上半年纯利同比增长48.6% 精准营销业务稳步提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2462174837","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462174837?lang=zh_cn&edition=full","pubTime":"2024-08-28 10:20","pubTimestamp":1724811652,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,医脉通涨超6%,截至发稿,涨6%,报8.13港元,成交额636.92万港元。消息面上,医脉通发布2024年中期业绩,收益人民币2.43亿元,同比增加40.3%;母公司拥有人应占溢利1.47亿元,同比增加48.6%;非香港财务报告准则经调整净溢利1.56亿元,同比增加30.3%;每股基本盈利20.18分,拟派发中期股息每股12.05分,上年同期派10.67分。截止2024年6月30日止六个月集团精准营销及企业解决方案的收入同比42.7%至人民币2.25亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1172831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","02192","BK1587"],"gpt_icon":0},{"id":"2462424171","title":"医脉通(02192)上涨5.61%,报8.1元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2462424171","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462424171?lang=zh_cn&edition=full","pubTime":"2024-08-28 10:13","pubTimestamp":1724811197,"startTime":"0","endTime":"0","summary":"8月28日,医脉通(02192)盘中上涨5.61%,截至10:13,报8.1元/股,成交339.95万元。医脉通科技有限公司主要业务是开发医药学工具软件,包括《全医药学大词典》、《临床用药参考》、《医学文献王》等,并创建了拥有超过300万注册医生的《医脉通》平台。此外,公司还为药企提供精准、高效的数字营销服务,已发展成为专业的医学信息服务及精准数字营销服务提供商。截至2024年中报,医脉通营业总收入2.43亿元、净利润1.47亿元。8月27日,2024年中期每股派人民币0.1205元(相当于港币0.132元),除权除息日2024-10-22,派息日2024-11-18(董事会预案)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/28101342802685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02192","BK1587","BK1189"],"gpt_icon":0},{"id":"2462751861","title":"南向资金8月27日净买入医脉通0.65万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2462751861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462751861?lang=zh_cn&edition=full","pubTime":"2024-08-28 09:30","pubTimestamp":1724808612,"startTime":"0","endTime":"0","summary":"8月27日, 南向资金增持医脉通0.65万股,连续3日增持。截止当日收盘,港股通共持有医脉通1977.56万股,占流通股2.69%。医脉通近5个交易日下跌0.52%,港股通累计减持10.05万股;近20个交易日上涨4.35%,港股通累计增持36.01万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408280933179f5ff29a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408280933179f5ff29a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1189","02192"],"gpt_icon":0},{"id":"2462156625","title":"【港股通】医脉通(02192)中期溢利增长48.62% 派中期股息0.1205元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2462156625","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462156625?lang=zh_cn&edition=full","pubTime":"2024-08-27 17:14","pubTimestamp":1724750053,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医脉通(02192)公布截至2024年6月30日止六个月中期业绩,录得母公司拥有人应占溢利1.47亿元(人民币,下同),同比增长48.62%,每股基本盈利20.18分。拟派中期股息每股0.1205元(0.132港元)。期内,集团收益2.43亿元,同比增长40.31%;毛利为1.47亿元,同比增长40.02%。其中,精准营销及企业解决方案收入2.26亿元,同比增长42.7%;医学知识解决方案收入842.2万元,同比增长4.6%;智能患者管理解决方案收入938.1万元,同比增长4.2%。","market":"other","thumbnail":"https://static.szfiu.com/news/20200908/MTc4YzRjNTJiOWFmNWRhNjdlMWVhYTgzMTk5OTQyMTM4MDAx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MTc4YzRjNTJiOWFmNWRhNjdlMWVhYTgzMTk5OTQyMTM4MDAx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1943132","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","YANG","BK1587","BK1189","07226","HSTECH","02192"],"gpt_icon":0},{"id":"2462153863","title":"医脉通(02192.HK)上半年净利润超1.5亿元 同比增长50.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462153863","media":"格隆汇","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462153863?lang=zh_cn&edition=full","pubTime":"2024-08-27 16:46","pubTimestamp":1724748363,"startTime":"0","endTime":"0","summary":"集团在拓展收入的同时不断提升盈利能力,集团的净利润由截至2023年6月30日止六个月的人民币1.017亿元增加至截至2024年6月30日止六个月的人民币1.527亿元,同比增长50.2%。截至2024年6月30日止六个月的经调整净利润和经调整净利润率分别为人民币1.561亿元和64.1%,继续在行业中保持领先地位。因此,截止2024年6月30日止六个月集团精准营销及企业解决方案的收入较2023年同期的人民币1.581亿元增长42.7%至人民币2.256亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240827164603ab600221&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240827164603ab600221&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02192"],"gpt_icon":0},{"id":"2462158926","title":"医脉通(02192)将于11月18日派发中期股息每股0.1205元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462158926","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462158926?lang=zh_cn&edition=full","pubTime":"2024-08-27 16:45","pubTimestamp":1724748343,"startTime":"0","endTime":"0","summary":"医脉通(02192)发布公告,将于2024年11月18日派发截至2024年6月30...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_4.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_4.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1171671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02192","BK1189","BK1587"],"gpt_icon":0},{"id":"2462115887","title":"医脉通(02192)发布中期业绩,经调整净溢利1.56亿元 同比增加30.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462115887","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462115887?lang=zh_cn&edition=full","pubTime":"2024-08-27 16:40","pubTimestamp":1724748026,"startTime":"0","endTime":"0","summary":"截至2024年6月30日止6个月,集团的收入约2.43亿元,较去年同期增长40.3%。集团在拓展收入的同时不断提升盈利能力,集团的净利润由截至2023年6月30日止6个月的1.02亿元增加至截至2024年6月30日止6个月的1.53亿元,同比增长50.2%。截至2024年6月30日止6个月的经调整净利润和经调整净利润率分别为1.56亿元和64.1%,继续在行业中保持领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1171656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02192","BK1587","BK1189"],"gpt_icon":0},{"id":"2462513073","title":"《业绩》医脉通(02192.HK)半年纯利1.47亿元人民币升48.6% 中期息12.05分人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2462513073","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462513073?lang=zh_cn&edition=full","pubTime":"2024-08-27 16:33","pubTimestamp":1724747580,"startTime":"0","endTime":"0","summary":"医脉通公布截至今年6月底止中期业绩,营业额2.43亿元人民币(下同),按年升40.3%。纯利1.47亿元,按年升48.6%;每股盈利20.18分。派中期息12.05分,上年同期派10.67分。(港股报价延迟最少十五分钟。沽空资料截至 2024-08-27 12:25。)过往派息公布日期派息事项派息内容2024/03/25末期业绩普通股息:人民币 0.1248 2023/08/29中期业绩普通股息:人民币 0.1067﹙相当于港元 0.1165﹚2023/03/23末期业绩普通股息:人民币 0.0654﹙相当于港元 0.0747﹚2022/08/25中期业绩无派息 AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220225103358284_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220225103358284_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1375724/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02192","BK1189","BK1587"],"gpt_icon":0},{"id":"2457366560","title":"医脉通(02192.HK)拟8月27日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2457366560","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457366560?lang=zh_cn&edition=full","pubTime":"2024-08-08 16:52","pubTimestamp":1723107178,"startTime":"0","endTime":"0","summary":"格隆汇8月8日丨医脉通(02192.HK)宣布,公司将于2024年8月27日(星期二)举行董事会会议,藉以(其中包括)考虑及批准公司及其附属公司截至2024年6月30日止六个月的中期业绩,并考虑派发中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808165258af9692cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808165258af9692cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02192","BK1189","BK1587"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0078},{"period":"3month","weight":-0.0078},{"period":"6month","weight":0.0227},{"period":"1year","weight":0.0381},{"period":"ytd","weight":-0.0979}],"compareEarnings":[{"period":"1week","weight":0.0448},{"period":"1month","weight":0.0287},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0917},{"period":"1year","weight":0.0071},{"period":"ytd","weight":0.0567}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"医脉通科技有限公司是一家主要运营在线专业医师平台的中国投资控股公司。该公司运营三个业务部门。精准营销及企业解决方案部门包括精准营销解决方案及企业解决方案。其中精准营销解决方案包括数字推送、营销咨询以及内容创建服务。企业解决方案的收益主要是软件即服务(SaaS)。医学知识解决方案部门主要提供专业医学信息和医疗软件服务。智能患者管理解决方案部门主要提供线上患者咨询及处方服务和患者管理服务。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.179583},{"month":2,"riseRate":0.333333,"avgChangeRate":0.000679},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.055193},{"month":4,"riseRate":0.666667,"avgChangeRate":0.025989},{"month":5,"riseRate":0,"avgChangeRate":-0.11026},{"month":6,"riseRate":0.666667,"avgChangeRate":0.100202},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.062441},{"month":8,"riseRate":1,"avgChangeRate":0.117784},{"month":9,"riseRate":0.5,"avgChangeRate":-0.015564},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.062041},{"month":11,"riseRate":0.666667,"avgChangeRate":0.228676},{"month":12,"riseRate":0,"avgChangeRate":-0.190084}],"exchange":"SEHK","name":"医脉通","nameEN":"MEDLIVE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医脉通(02192)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医脉通(02192)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医脉通,02192,医脉通股票,医脉通股票老虎,医脉通股票老虎国际,医脉通行情,医脉通股票行情,医脉通股价,医脉通股市,医脉通股票价格,医脉通股票交易,医脉通股票购买,医脉通股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医脉通(02192)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医脉通(02192)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}